Updates About Public Health

On Wednesday March 29, the Food and Drug Administration (FDA) approved a drug used to reverse the effects of an opioid overdose to be sold over the counter. Narcan, generically called naloxone, is a life-saving nasal spray that can be administered to individuals showing signs of an opioid overdose.

The Michigan Department of Health and Human Services (MDHHS) shared that its OTC approval has been a priority of the department for years as it will tremendously combat the opioid crisis.

The FDA first approved Narcan in 2015 as a drug that can be sold with a prescription. Now that it can be sold over the counter, priorities for the FDA and MDHHS include making it available as soon as possible at an affordable price.

Following testimony in the House Appropriations Subcommittee on Corrections, it was revealed that Michigan’s prisoner population has been steadily declining, but the mental and physical health caseload is on the rise.

About a third of Michigan’s prisoner population is currently on active mental health caseload. Approximately 446 patients are awaiting Hepatitis C treatment, while 69 patients are currently receiving treatment. The Michigan Department of Corrections (MDOC) adds about 11 new patients each month, spending an average of $15,122 per patient on Hepatitis C treatment. These costs are a significant portion of the MDOC budget, totaling over $300 million per year.

MDOC is also facing challenges regarding staffing, especially with corrections officers and healthcare staff. There are about 866 total corrections officer vacancies which is equivalent to about 15.3% of total corrections officers. MDOC is prioritizing staffing recruitment and retention efforts as well as combatting the increase in mental and physical health caseload.

On Thursday March 30, a federal judge in Texas ruled to overturn a portion of the Affordable Care Act in Braidwood Management. Inc. v. Becerra. This decision struck down the requirement that makes preventive services and screenings covered by health insurers with no additional cost to the patient. Services like screenings for cancer, heart disease, and high blood pressure could become costly, diminish access to affordable early detection, and put people’s health at risk.

Following this decision, Governor Whitmer directed the Michigan Department of Insurance and Financial Services (DFIS) to protect Michigan families and ensure access to no-cost preventive healthcare services. This decision in Braidwood Management. Inc. v. Becerra is however being appealed by the US Department of Justice.

On Thursday April 6, Governor Whitmer announced that insurers who represent 100% of the fully insured health insurance market will continue to cover no-cost preventive services for Michigan residents.